Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-07

FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved Accord Healthcare's supplemental application for montelukast sodium under ANDA202717, resulting in an updated approved product. Montelukast sodium …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Montelukast Sodium (Montelukast Sodium)

Snippet

SUPPL AP for MONTELUKAST SODIUM (MONTELUKAST SODIUM)